IQVIA HOLDINGS INC. (IQV) Shareholder Equity
- 2026-03-31: Treasury Stock, Common, ValueUSD $11.91B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-968.00M; Retained Earnings (Accumulated Deficit)USD $7.70B; Stockholders' Equity Attributable to ParentUSD $6.22B.
- 2025-12-31: Treasury Stock, Common, ValueUSD $11.36B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-943.00M; Retained Earnings (Accumulated Deficit)USD $7.42B; Stockholders' Equity Attributable to ParentUSD $6.50B.
- 2025-09-30: Treasury Stock, Common, ValueUSD $11.14B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-928.00M; Retained Earnings (Accumulated Deficit)USD $6.91B; Stockholders' Equity Attributable to ParentUSD $6.16B.
- 2025-06-30: Treasury Stock, Common, ValueUSD $11.14B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-882.00M; Retained Earnings (Accumulated Deficit)USD $6.58B; Stockholders' Equity Attributable to ParentUSD $5.78B.
IQVIA HOLDINGS INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Noncontrolling Interest, Increase from Business Combination USD | Common Stocks, Including Additional Paid in Capital USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Common Stock, Value, Issued USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Treasury Stock, Shares, Acquired shares | Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD | Noncontrolling Interest in Variable Interest Entity USD | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $11.91B | $-968.00M | $7.70B | $6.22B | $6.35B | 92.70M | 3 month · $557.00M | 3 month · $66.00M | (m) | $11.40B | 3 month · $-7.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $11.36B | $-943.00M | $7.42B | $6.50B | $6.63B | 89.50M | 12 month · $1.25B | 12 month · $227.00M | 12 month · $126.00M | $11.38B | 12 month · $8.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $11.14B | $-928.00M | $6.91B | $6.16B | $6.29B | 88.50M | (m) | 3 month · $51.00M | 9 month · $119.00M | $11.32B | 3 month · $3.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $11.14B | $-882.00M | $6.58B | $5.78B | $5.79B | 88.50M | 3 month · $613.00M | 3 month · $52.00M | (m) | $11.22B | 3 month · $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $10.53B | $-978.00M | $6.31B | $5.98B | $5.99B | 84.40M | 3 month · $429.00M | 3 month · $65.00M | 3 month · $8.00M | $11.17B | 3 month · $-1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $10.10B | $-1.04B | $6.07B | $6.07B | $6.07B | 82.10M | 12 month · $1.36B | 12 month · $181.00M | (m) | $11.14B | 12 month · $31.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $8.94B | $-826.00M | $5.63B | $6.97B | $6.97B | 76.50M | 3 month · $200.00M | 3 month · $46.00M | (m) | $11.11B | 3 month · $8.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $8.74B | $-949.00M | $5.34B | $6.71B | $6.71B | 75.70M | (m) | 3 month · $44.00M | (m) | $11.06B | 3 month · $11.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $8.74B | $-911.00M | $4.98B | $6.34B | $6.34B | 75.70M | (m) | 3 month · $49.00M | (m) | $11.02B | 3 month · $9.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $8.74B | $-867.00M | $4.69B | $6.11B | $6.11B | 75.70M | 12 month · $1.00B | 12 month · $191.00M | (m) | $11.03B | 12 month · $-51.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $8.51B | $-903.00M | $4.22B | $5.80B | $5.80B | 74.60M | 3 month · $145.00M | 3 month · $42.00M | (m) | $10.99B | 3 month · $9.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $8.36B | $-760.00M | $3.92B | $5.75B | $5.75B | 73.90M | 3 month · $495.00M | 3 month · $43.00M | (m) | $10.95B | 3 month · $7.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $7.87B | $-731.00M | $3.62B | $5.93B | $5.93B | 71.40M | 3 month · $129.00M | 3 month · $69.00M | (m) | $10.91B | 3 month · $25.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $7.74B | $-727.00M | $3.33B | $5.76B | $5.76B | 70.70M | 12 month · $1.17B | 12 month · $192.00M | (m) | $10.90B | 12 month · $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $7.71B | $-898.00M | $3.11B | $5.35B | $5.93B | 70.50M | 3 month · $129.00M | 3 month · $69.00M | (m) | $10.85B | 3 month · $25.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $7.57B | $-697.00M | $2.82B | $5.35B | $5.35B | 69.70M | 3 month · $590.00M | 3 month · $47.00M | (m) | $10.79B | 3 month · $-14.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $6.97B | $-419.00M | $2.57B | $5.92B | $5.92B | 66.90M | 3 month · $403.00M | 3 month · $35.00M | (m) | $10.74B | 3 month · $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $6.57B | $-406.00M | $2.24B | $6.04B | $6.04B | 65.20M | 12 month · $406.00M | 12 month · $157.00M | (m) | $10.78B | 12 month · $12.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $6.40B | $-445.00M | $1.93B | $5.83B | $5.83B | 64.50M | 3 month · $125.00M | 3 month · $48.00M | (m) | $10.75B | 3 month · $-3.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $6.27B | $-327.00M | $1.66B | $5.76B | $5.76B | 64.00M | 3 month · $45.00M | 3 month · $42.00M | (m) | $10.70B | 3 month · $-3.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $6.23B | $-376.00M | $1.49B | $5.95B | $6.24B | 63.80M | 3 month · $62.00M | 3 month · $30.00M | (m) | $11.07B | 3 month · $-1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $6.17B | $-205.00M | $1.28B | $6.00B | $6.28B | 63.50M | 12 month · $433.00M | 12 month · $90.00M | (m) | $11.10B | 12 month · $-10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $6.07B | $-317.00M | $1.16B | $5.85B | $6.11B | 62.80M | (m) | 3 month · $30.00M | (m) | $11.07B | 3 month · $-2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $6.07B | $-444.00M | $1.06B | $5.59B | $5.85B | 62.80M | 3 month · $0.00 | 3 month · $30.00M | (m) | $11.04B | 3 month · $12.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $6.07B | $-485.00M | $1.08B | $5.54B | $5.80B | 62.80M | 3 month · $332.00M | 3 month · $7.00M | (m) | $11.01B | 3 month · $-16.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $5.73B | $-311.00M | $998.00M | $6.00B | $6.26B | 60.70M | 12 month · $963.00M | 12 month · $137.00M | (m) | $11.05B | 12 month · $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $5.46B | $-377.00M | $982.00M | $6.13B | $6.39B | 58.80M | 3 month · $313.00M | 3 month · $30.00M | (m) | $10.99B | 3 month · $-2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $5.15B | $-215.00M | $925.00M | $6.52B | $6.78B | 56.80M | 3 month · $236.00M | 3 month · $29.00M | (m) | $10.96B | 3 month · $3.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $4.92B | $-262.00M | $865.00M | $6.62B | $6.87B | 55.00M | 3 month · $145.00M | 3 month · $21.00M | (m) | $10.93B | 3 month · $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $4.77B | $-224.00M | $807.00M | $6.71B | $6.95B | 54.00M | 12 month · $1.40B | 12 month · $108.00M | (m) | $10.90B | 12 month · $11.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $-220.00M | $726.00M | $7.21B | $7.46B | (m) | 3 month · $134.00M 9 month · $792.00M | 3 month · $25.00M | 3 month · $0.00 | $10.88B | (m) | (m) | $4.17B | (m) | (m) | (m) | (m) | 9 month · 7.52M | (m) | (m) | (m) | (m) | 48.90M |
| 2018-06-30 | (m) | $-104.00M | $665.00M | $7.36B | $7.61B | (m) | 3 month · $573.00M 6 month · $659.00M | 3 month · $25.00M | 3 month · $10.00M | $10.84B | 3 month · $1.00M | (m) | $4.03B | (m) | (m) | (m) | (m) | 6 month · 6.47M | (m) | (m) | (m) | (m) | 47.90M |
| 2018-03-31 | (m) | $254.00M | $605.00M | $8.20B | $8.45B | (m) | 3 month · $86.00M | 3 month · $20.00M | (m) | $10.80B | 3 month · $-1.00M | (m) | $3.46B | (m) | (m) | (m) | (m) | 3 month · 874.63K | (m) | (m) | (m) | (m) | 42.30M |
| 2017-12-31 | $3.37B | $49.00M | $538.00M | $8.00B | $8.24B | 41.40M | 12 month · $2.37B | 12 month · $180.00M | (m) | $10.78B | (m) | (m) | $3.37B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 41.40M |
| 2017-09-30 | (m) | $-79.00M | $-166.00M | $7.26B | $7.51B | (m) | (m) | (m) | (m) | $10.76B | (m) | (m) | $3.25B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $5.00M 9 month · $18.00M | 40.20M |
| 2017-06-30 | (m) | $-233.00M | $-255.00M | $7.54B | $7.77B | (m) | (m) | (m) | (m) | $10.72B | (m) | (m) | $2.69B | (m) | (m) | (m) | (m) | (m) | (m) | $35.00M | (m) | 3 month · $10.00M 6 month · $13.00M | 34.30M |
| 2017-03-31 | (m) | $-444.00M | $-325.00M | $7.57B | $7.80B | (m) | (m) | (m) | (m) | $10.66B | (m) | (m) | $2.32B | (m) | (m) | (m) | (m) | (m) | (m) | $38.00M | (m) | (m) | 29.80M |
| 2016-12-31 | (m) | $-570.00M | $-399.00M | $8.63B | $8.78B | (m) | 12 month · $1.00B | 12 month · $76.00M | 12 month · $1.00M | $10.60B | 12 month · $-22.00M | (m) | $1.00B | (m) | (m) | (m) | (m) | (m) | (m) | $49.00M | (m) | 12 month · $41.00M | 12.90M |
| 2016-09-30 | (m) | $-140.98M | $-221.22M | $-313.43M | $-81.93M | (m) | (m) | (m) | (m) | $48.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $2.00M | $49.43M | (m) | (m) | (m) |
| 2016-06-30 | (m) | $-139.09M | $-320.38M | $-458.29M | $-228.70M | (m) | (m) | (m) | (m) | $1.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $1.00M | $46.93M | (m) | (m) | (m) |
| 2016-03-31 | (m) | $-105.76M | $-354.97M | $-434.81M | $-205.94M | (m) | (m) | (m) | (m) | $25.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $42.57M | (m) | (m) | (m) |
| 2015-12-31 | (m) | $-111.00M | $-462.00M | $-564.00M | $-336.00M | (m) | (m) | 12 month · $31.00M | (m) | $9.00M | 12 month · $-13.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $39.00M | (m) |
| 2015-09-30 | (m) | $-95.46M | $-550.15M | $-406.02M | $-179.93M | (m) | (m) | 9 month · $23.29M | (m) | $239.59M | 9 month · $10.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $231.03M | (m) | (m) | 9 month · $35.14M | (m) |
| 2015-06-30 | (m) | $-68.84M | $-661.43M | $-701.76M | $-701.68M | (m) | (m) | (m) | (m) | $28.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $-88.95M | $-702.40M | $-612.39M | $-612.31M | (m) | (m) | (m) | (m) | $178.97M | 3 month · $-3.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $-59.09M | $-788.80M | $-704.06M | $-703.00M | (m) | (m) | 12 month · $26.00M | (m) | $143.83M | 12 month · $-2.00M | $143.83M | (m) | (m) | (m) | (m) | 12 month · $105.00K | (m) | (m) | (m) | (m) | 12 month · $20.00M | (m) |
| 2014-09-30 | (m) | $-27.05M | $-877.22M | $-536.26M | $-536.23M | (m) | (m) | (m) | (m) | (m) | 9 month · $774.00K | $368.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $2.24M | $-969.88M | $-621.55M | $-621.61M | (m) | (m) | (m) | (m) | (m) | 6 month · $2.34M | $346.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $-393.00K | $-1.05B | $-559.47M | $-559.52M | (m) | (m) | (m) | (m) | (m) | 3 month · $2.58M | $495.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $-376.00K | $-1.15B | $-667.41M | $-667.00M | (m) | (m) | 12 month · $20.78M | (m) | (m) | 12 month · $8.74M | $478.14M | (m) | (m) | (m) | (m) | 12 month · $35.44M | (m) | (m) | (m) | (m) | 12 month · $16.20M | (m) |
| 2013-09-30 | (m) | $-3.89M | $-1.22B | $-711.97M | $-711.97M | (m) | (m) | (m) | (m) | (m) | 9 month · $-7.38M | $510.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $-18.19M | $-1.28B | $-798.06M | $-797.89M | (m) | (m) | (m) | (m) | (m) | (m) | $505.07M | (m) | $-9.36M | $536.00K | $7.72M | (m) | (m) | (m) | (m) | $-29.73M | (m) | (m) |
| 2013-03-31 | (m) | $-8.39M | $-1.32B | $-1.32B | $-1.32B | (m) | (m) | (m) | (m) | (m) | 3 month · $-2.71M | $9.23M | (m) | $-928.00K | $535.00K | $7.97M | (m) | (m) | (m) | (m) | $-34.06M | (m) | (m) |
| 2012-12-31 | (m) | $7.70M | $-1.37B | $-1.36B | $-1.36B | (m) | (m) | 12 month · $25.77M | 12 month · $580.00K | (m) | 12 month · $-2.91M | $4.55M | (m) | $19.35M | $467.00K | $-5.02M | (m) | (m) | (m) | (m) | $-33.58M | 12 month · $465.00K | (m) |
| 2012-09-30 | (m) | $16.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $-1.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $22.87M | (m) | (m) | $-969.60M | (m) | (m) | (m) | 12 month · $454.00K | (m) | 12 month · $-8.59M | (m) | (m) | $-531.00K | (m) | $-2.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $45.58M | (m) | (m) | $-900.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |